pergolide has been researched along with istradefylline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jenner, P; Kanda, T; Kawai-Uchida, M; Mori, A; Okita, E; Soshiroda, K; Uchida, S | 2 |
| Haga, R; Kon, T; Tomiyama, M; Ueno, T | 1 |
3 other study(ies) available for pergolide and istradefylline
| Article | Year |
|---|---|
The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Callithrix; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Female; Indoles; Levodopa; Male; Motor Activity; Pergolide; Purines; Receptor, Adenosine A2A | 2015 |
The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets.
Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Dopamine Agonists; Drug Therapy, Combination; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Pergolide; Purines | 2015 |
The factors associated with impulse control behaviors in Parkinson's disease: A 2-year longitudinal retrospective cohort study.
Topics: Adenosine A2 Receptor Antagonists; Age Factors; Aged; Antiparkinson Agents; Calcium Channel Blockers; Case-Control Studies; Catechols; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Impulsive Behavior; Japan; Longitudinal Studies; Male; Nitriles; Parkinson Disease; Pergolide; Purines; Retrospective Studies; Surveys and Questionnaires; Zonisamide | 2018 |